Galapagos NV DSO 2011-2026 | GLPG

DSO Jährlich Galapagos NV

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	56.5	148	72.6	84.8	89	-

Alle Zahlen in EUR-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
148	56.5	90.2

DSO anderer Aktien in der Pharmaeinzelhändler

Name	DSO	Preis	% 24h	Marktkapitalisierung	Land
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.85	3.22 %	$ 9.26 B	Australia
Alnylam Pharmaceuticals ALNY	58.1	$ 327.75	-1.69 %	$ 42.9 B	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 21.62	-0.28 %	$ 1.01 B	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.1	-4.32 %	$ 5.1 M	Israel
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	62.9	$ 1.41	-9.03 %	$ 363 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	103	$ 4.18	-1.5 %	$ 447 M	USA
Arcutis Biotherapeutics ARQT	106	$ 24.23	-1.42 %	$ 3.08 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.48	-0.67 %	$ 394 M	Britain
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Clearside Biomedical CLSD	61.7	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	321	$ 33.44	-1.27 %	$ 2.22 B	USA
bluebird bio BLUE	2.47	-	-	$ 546 M	USA